News
FDA Advisory Committee Votes Unanimously in Favor Of COMIRNATY® Booster for Emergency Use in People 65 and Older and Certain High-risk Populations
Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) announced today that the U.S. Food and Drug Administration’s (FDA) Vaccines and Related Biological Products Advisory Committee (VRBPAC) voted
Chevron Accelerates Lower Carbon Ambitions
During its Energy Transition Spotlight, Chevron Corporation (NYSE: CVX) announced plans to invest more capital to grow lower carbon energy businesses.
“Chevron intends to be a leader in advancing
Chevron, Enterprise Explore Carbon Storage Business Opportunities
Chevron U.S.A. Inc., through its Chevron New Energies division, and a subsidiary of Enterprise Products Partners L.P. (NYSE: EPD) announced a framework to study and evaluate opportunities for
Chevron, Mercuria Announce CNG Fueling Network Joint Venture
Chevron U.S.A. Inc., a subsidiary of Chevron Corporation (NYSE: CVX), announced today the signing of definitive agreements to form a joint venture with Mercuria Energy Trading (Mercuria), one of
Chevron, Gevo Announce Intent to Pursue Sustainable Aviation Fuel Investment
Chevron U.S.A. Inc., a subsidiary of Chevron Corporation (NYSE: CVX), and Gevo, Inc. (NASDAQ: GEVO) today announced a letter of intent to jointly invest in building and operating one or more new
ExxonMobil Announces Discovery at Pinktail, Offshore Guyana
ExxonMobil today said it made a discovery at Pinktail in the Stabroek Block offshore Guyana. The Pinktail well encountered 220 feet (67 meters) of net pay in high quality hydrocarbon bearing
UK’s MHRA Grants Marketing Authorisation for Pfizer’s CIBINQO® (abrocitinib) for Adults and Adolescents With Moderate to Severe Atopic Dermatitis
Pfizer Inc. (NYSE: PFE) today announced that the UK Medicines and Healthcare products Regulatory Agency (MHRA) has granted Great Britain marketing authorization for CIBINQO® (abrocitinib), an oral
Chevron, Caterpillar Announce Collaboration Agreement on Hydrogen
Chevron U.S.A. Inc., a subsidiary of Chevron Corporation (NYSE: CVX), and Caterpillar Inc. (NYSE: CAT) today announced a collaboration agreement to develop hydrogen demonstration projects in
Chevron, Delta Air Lines, and Google Announce Intent to Measure Sustainable Aviation Fuel Emissions Data, Increase Industry Transparency
Chevron U.S.A. Inc., through its Chevron Products Company division (Chevron), Delta Air Lines (Delta), and Google today announced a memorandum of understanding (MOU) to track sustainable aviation
Pfizer Invites Public to Listen to Two Webcasts of Pfizer Discussions at Upcoming Healthcare Conferences
Pfizer Inc. (NYSE: PFE) invites investors and the general public to listen to two webcasts of discussions with Pfizer executives at two upcoming healthcare conferences.
Frank D’Amelio, Chief
ExxonMobil to Certify Natural Gas, Help Customers Meet Environmental Goals
ExxonMobil said today it has signed an agreement with an independent validator, non-profit MiQ, to begin the certification process for natural gas produced at its Permian Basin facilities at Poker
Chevron Commits $3 Million to Support Hurricane Ida Relief and Recovery Efforts
Chevron Corporation (NYSE: CVX) announced today it is making a commitment of $3 million to support relief and recovery efforts underway in the communities affected by Hurricane Ida.
“As a major
Pfizer Announces Start of Phase 3 Clinical Trial in Adults for Its Investigational Vaccine Against Respiratory Syncytial Virus (RSV)
Pfizer Inc. (NYSE:PFE) today announced the initiation of RENOIR (RSV vaccine Efficacy study iN Older adults Immunized against RSV disease), a Phase 3 clinical trial evaluating the efficacy
Walmart To Participate in Barclays Global Consumer Staples Conference and Goldman Sachs Global Retailing Conference
Walmart Inc. (NYSE: WMT) announced today that Brett Biggs, executive vice president and chief financial officer of Walmart Inc., and John Furner, executive vice president and chief executive
Positive Top-Line Results From Pfizer’s Phase 3 JADE DARE Trial Comparing the Efficacy of Abrocitinib and Dupilumab for Moderate to Severe Atopic Dermatitis
Pfizer Inc. (NYSE: PFE) today announced that JADE DARE (B7451050), a 26-week, randomized, double-blind, double-dummy, active-controlled, multi-center Phase 3 study, met its co-primary and key
Pfizer Announces New Chief Business Innovation Officer
Pfizer Inc. (NYSE: PFE) today announced that Aamir Malik has joined the company as Executive Vice President and Chief Business Innovation Officer. Mr. Malik will be a member of Pfizer’s Executive
Pfizer and BioNTech Announce Collaboration With Brazil’s Eurofarma to Manufacture COVID-19 Vaccine Doses for Latin America
Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced the signing of a letter of intent with Eurofarma Laboratórios SA, a Brazilian biopharmaceutical company, to manufacture
Pfizer and BioNTech Initiate Rolling Submission of Supplemental Biologics License Application to U.S. FDA for Booster Dose of COMIRNATY® in Individuals 16 and Older
Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced the initiation of a supplemental Biologics License Application (sBLA) to the U.S. Food and Drug Administration (FDA) for the
ExxonMobil Affiliate to Produce Renewable Diesel to Help Reduce Transportation Emissions in Canada
ExxonMobil today announced its majority-owned affiliate, Imperial Oil Ltd., is moving forward with plans to produce renewable diesel at a new complex at its Strathcona refinery in Edmonton, Canada
Advisory: Chevron Corporation’s Energy Transition Spotlight Conference Call and Webcast
Chevron Corporation (NYSE: CVX), one of the world’s leading energy companies, will hold its Energy Transition Spotlight conference call and webcast on Tuesday, September 14, 2021 at 10:00 a.m. ET
Pfizer-BioNTech COVID-19 Vaccine COMIRNATY® Receives Full U.S. FDA Approval for Individuals 16 Years and Older
Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced that the U.S. Food and Drug Administration (FDA) approved the Biologics License Application (BLA) for COMIRNATY® (COVID-19
Pfizer to Acquire Trillium Therapeutics Inc.
Pfizer Inc. (NYSE: PFE) and Trillium Therapeutics Inc. (NASDAQ/TSX: TRIL) today announced that the companies have entered into a definitive agreement under which Pfizer will acquire Trillium, a
XELJANZ® (tofacitinib citrate) Receives Marketing Authorization in the European Union for the Treatment of Active Polyarticular Juvenile Idiopathic Arthritis and Juvenile Psoriatic Arthritis
Pfizer Inc. (NYSE: PFE) announced today that the European Commission (EC) has approved XELJANZ® (tofacitinib) for the treatment of active polyarticular juvenile idiopathic arthritis (JIA) and
NIKE, Inc. Announces First Quarter Fiscal 2022 Earnings and Conference Call
NIKE, Inc. (NYSE: NKE) plans to release its first quarter fiscal 2022 financial results on Thursday, September 23, 2021, at approximately 1:15 p.m. PT, following the close of regular stock market
American Express Ranks No. 1 Among National Issuers in the J.D. Power U.S. Credit Card Customer Satisfaction Study for the Second Consecutive Year
American Express Company (NYSE: AXP) received the number one ranking for customer satisfaction among national credit card issuers, according to the J.D. Power 2021 U.S. Credit Card Satisfaction